Crossmark

Abstraction hierarchy to define biofoundry workflows and operations for interoperable synthetic biology research and applications

Crossref DOI link: https://doi.org/10.1038/s41467-025-61263-6

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Haseong https://orcid.org/0000-0002-4594-5791
Hillson, Nathan J. https://orcid.org/0000-0002-9169-3978
Cho, Byung-Kwan https://orcid.org/0000-0003-4788-4184
Sung, Bong Hyun https://orcid.org/0000-0002-8992-1118
Lee, Dae-Hee https://orcid.org/0000-0002-0423-9057
Kim, Dong-Myung https://orcid.org/0000-0001-7875-0694
Oh, Min-Kyu https://orcid.org/0000-0001-6406-3930
Chang, Matthew Wook https://orcid.org/0000-0001-6448-6319
Jin, Yong-Su https://orcid.org/0000-0002-4464-9536
Rosser, Susan J.

Vegh, Peter https://orcid.org/0000-0002-0133-3240
Fragkoudis, Rennos

Le Feuvre, Rosalind

Scrutton, Nigel S. https://orcid.org/0000-0002-4182-3500
Storch, Marko https://orcid.org/0000-0003-1503-8282
Seong, Wonjae https://orcid.org/0000-0003-2144-5650
Freemont, Paul S. https://orcid.org/0000-0002-5658-8486
Lee, Seung-Goo https://orcid.org/0000-0003-4539-9812
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 14 January 2025

Accepted: 18 June 2025

First Online: 1 July 2025

Competing interests

: The authors declare the following competing financial interest(s): N.J.H. has financial interests in TeselaGen Biotechnologies and Ansa Biotechnologies. All other authors declare no competing interests.